Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,298,010
+$415,162 QoQ
Shares Held
17,080
-4.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#1,412
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ledyard National Bank holds $47,693,201 across 10 Drug Manufacturers - General names. ABBV ranks #6 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,244 | $11,490,617 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,938 | $9,244,033 | |
| 3 | AMGN |
Amgen Inc
|
25,394 | $9,195,674 | |
| 4 | LLY |
ELI LILLY & Co
|
4,276 | $5,128,762 | |
| 5 | PFE |
Pfizer Inc
|
181,271 | $4,365,005 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
17,080 | $4,298,010 | |
| 7 | GSK |
GSK plc
|
48,213 | $2,527,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
17,142 | $987,721 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,298,010 | 17,080 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,882,848 | 17,853 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,299,266 | 18,816 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,546,750 | 19,637 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,638,336 | 19,601 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,125,238 | 19,689 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,670,215 | 20,654 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,073,221 | 20,626 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $3,402,785 | 19,839 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $3,602,119 | 19,781 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,081,732 | 19,886 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,538,044 | 17,027 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,295,125 | 17,035 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,759,331 | 17,314 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,887,808 | 17,869 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,412,960 | 17,979 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $2,829,324 | 18,473 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $3,164,062 | 19,518 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,694,865 | 19,903 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,434,086 | 22,565 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $2,822,082 | 25,054 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,757,445 | 25,480 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $2,497,880 | 23,312 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $2,106,714 | 24,052 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $2,410,319 | 24,550 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $1,866,807 | 24,502 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||